Q2 2026 saw 4% net sales growth and 11% ARR growth, with recurring revenue at 87% of sales. A major reorganization reduced costs and headcount, with full savings expected from Q3. EBIT and EBITDA remained negative, but cost efficiency and strategic focus are set to improve results.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.